CX3CL1 and neoplasm: Since CX3CL1 signaling through CX3CR1 leads to secretion of immunosuppressive mediators by the CT26 tumor (Figures 5A–D), we hypothesized that CX3CR1 antibody could reduce the secretion of these mediators.